Since P38 acts as a tumour suppressor among MAPKs, with higher activation levels observed in never smoker LUAD, this indicates that its action is different in the context of adenocarcinoma cells in never smokers, given their unique molecular and biological characteristics. This evidence concerns the gene MAPK14 and neoplasm.